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Bone morphogenetic protein (Bmp) signaling is critical for organismal development and homeostasis. To elucidate Bmp2 function in the
vascular/hematopoietic lineages we generated a new transgenic mouse line in which ectopic Bmp2 expression is controlled by the Tie2
promoter. Tie2CRE/+;Bmp2tg/tg mice develop aortic valve dysfunction postnatally, accompanied by pre-calcific lesion formation in valve
leaflets. Remarkably, Tie2CRE/+;Bmp2tg/tg mice develop extensive soft tissue bone formation typical of acquired forms of heterotopic
ossification (HO) and genetic bone disorders, such as Fibrodysplasia Ossificans Progressiva (FOP). Ectopic ossification in Tie2CRE/+;Bmp2tg/tg
transgenic animals is accompanied by increased bone marrow hematopoietic, fibroblast and osteoblast precursors and circulating pro-
inflammatory cells. Transplanting wild-type bone marrow hematopoietic stem cells into lethally irradiated Tie2CRE/+;Bmp2tg/tg mice
significantly delays HO onset but does not prevent it. Moreover, transplanting Bmp2-transgenic bone marrow into wild-type recipients
does not result in HO, but hematopoietic progenitors contribute to inflammation and ectopic bone marrow colonization rather than to
endochondral ossification. Conversely, aberrant Bmp2 signaling activity is associated with fibroblast accumulation, skeletal muscle fiber
damage, and expansion of a Tie2+ fibro-adipogenic precursor cell population, suggesting that ectopic bone derives from a skeletal
muscle resident osteoprogenitor cell origin. Thus, Tie2CRE/+;Bmp2tg/tg mice recapitulate HO pathophysiology, and might represent a useful
model to investigate therapies seeking to mitigate disorders associated with aberrant extra-skeletal bone formation.
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INTRODUCTION
Bone morphogenetic proteins (BMPs) regulate fundamental
processes in development and organismal homeostasis [1]. During
canonical Bmp signaling, BMPs ligands bind to BMP type I
receptors (BMPRIs), or activin-like kinase (ALK) 2,3, or 6. This
complex binds to BMP type II receptor (BMPRII), which phosphor-
ylates BMPRI, which in turn phosphorylates regulatory-Smads
(Smad1/5/8). Phosphorylated Smad1/5/8 binds to nuclear Smad4,
forming a nuclear complex that accumulates in the nucleus, where
it is recruited to transcriptional complexes to mediate BMP-driven
gene expression [2]. BMPs were discovered owing to their
fundamental role in bone formation and homeostasis [1], and
BMP2 is critical for chondrocyte proliferation and endochondral
bone maturation, and necessary for bone fracture healing [3, 4].
Heterotopic ossification (HO) is bone formation at extra-skeletal
sites, including muscle, tendon, ligament, and other connective
tissues, and a complication of injury and surgery [5, 6]. HO occurs
through intramembranous and endochondral bone formation,
resembling fracture repair processes. Lesions are characterized by
immune infiltration in damaged connective tissue, which is
eventually replaced by endochondral bone through fibroblast
proliferation, mesenchymal condensation, and chondro-
osteogenic differentiation [6, 7]. Subsequently, the woven bone
gives way to the lamellar bone and marrow stroma, with
hematopoietic progenitors, adipocytes, osteoblasts and osteo-
clasts, while capillary-like vessels give rise to bone marrow
(BM) sinusoid-type vessels.
Acquired HO is relatively common but its etiology is poorly
understood [6]. In contrast, genetic forms, like Fibrodysplasia
ossificans progressiva (FOP; OMIM #135100, ORPHA337) are rare,
but provide mechanistic insight [8–10]. FOP patients have
progressive spontaneous and injury-induced HO resulting in
complete mobility loss. FOP is caused by a mutation in the gene
encoding the type I ACVR1/ALK2 BMP receptor [11]. The ACVR1-
R206H mutant receptor acquires the ability to respond to the
TGFß family ligand Activin A [12, 13], and becomes sensitive to
other BMPs [14–16]. ACVR1 mutations alone cannot explain the
recurrent “flare-ups” resulting in extra skeletal ossification
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following trauma, muscular fatigue, or other inflammatory insults,
which also trigger acquired forms of HO. The innate immune
system [17, 18] and local “niche” soft tissue microenvironment
[19, 20] need to be further characterized to help clarify this issue.
Moreover, Activin A seems to play a significant role in the initial
steps of FOP during immune infiltration subsequent to injury.
However, once ectopic bone is fused to the normal bone skeleton,
additional canonical BMP ligands may be required to sustain
ectopic bone development.
The identification of bone osteoprogenitors has generated
considerable interest [21, 22]. Skeletal muscle-resident cells including
myoblasts [23, 24], satellite cells [25] or fibroadipogenic progenitors
(FAPs) have osteogenic differentiation ability [26, 27]. Hematopoietic
progenitors participate in bone formation at sites of tissue
inflammation, but are insufficient to initiate this process [28, 29].
Endothelial cells in mice constitutively expressing ACVR1-R206H,
transform into mesenchymal cells with progenitor properties, that
give rise to ectopic bone [30]. However, lineage tracing using a
Tie2CRE driver line and local transplantation of Tie2CRE-derived
endothelial cells into skeletal muscle have excluded the endothelium
as a source of ectopic bone formation [31]. Rather, non-endothelial
Tie2+ resident skeletal muscle stem cells including FAP osteopro-
genitors appear to be the principal FOP cells-of-origin [31, 32].
In view of ACVR1 receptor activation complexity, the uncer-
tainty of target osteo-progenitors, and modulating “niche” factors,
disease modeling is necessary to better understand both acquired
and genetic HO. Bmp2 plays fundamental roles in cardiac valves
formation and heart chamber patterning [33, 34], but its cardiac
overexpression causes lethality [35, 36]. To study Bmp2 vascular
gain-of-function postnatally, we generated Tie2CRE/+;Bmp2tg/tg
mice, which overexpress Bmp2 in hematopoietic/endothelial
lineages. These mice survive birth, develop pre-calcific valve
disease and a systemic bone disorder in skeletal muscle and other
connective tissues, resulting in severe skeletal deformities whose
nature we have investigated.
RESULTS
Endothelial Bmp2 overexpression results in valve dysfunction
We previously generated a transgenic mouse line in which CAG-
driven Bmp2 expression is activated upon Cre-mediated removal of
a β-Geo-stop cassette [35] (Supplementary Fig. 1A). We crossed the
CAG-Bmp2 allele with Tie2CRE line, which is active in hematopoietic/
endothelial lineages from E7.5 onwards [37]. Vascular GFP reporter
expression was observed at E9.5, confirming Cre-mediated recom-
bination (Supplementary Fig. 1B).
Ectopic Bmp2 signaling leads to osteogenic differentiation of
valve interstitial cells [38]. To determine the effect of increased
endothelial Bmp2 expression on valve function, we generated
Tie2CRE/+;Bmp2tg/tg mice. At 16 weeks, circulating Bmp2 levels were
almost six-fold higher than in WT animals (Fig. 1A). Tie2CRE/+;
Bmp2tg/tg mice showed shortened pulmonary acceleration time
and acceleration to ejection time ratio by ultrasound (Fig. 1B),
indicating pulmonary hypertension potentially leading to respira-
tory insufficiency. Tie2CRE/+;Bmp2tg/tg mice displayed significantly
increased aortic valve mean, peak velocity and pressure gradient
(Fig. 1C, D). Three of seven animals displayed chondrogenic and
lipid droplet islands at the leaflet base (Fig. 1E), indicative of pre-
calcific disease. These results indicate that ectopic endothelial
and/or hematopoietic Bmp2 expression leads to aortic valve
dysfunction compatible with a pre-calcific valve stage.
Hematopoietic/endothelial Bmp2 overexpression causes a HO
During these studies, we found that Tie2CRE/+;Bmp2tg/tg mice
develop severe scoliosis and ankylosis with depressed locomotor
behavior and respiratory insufficiency. Extensive HO was diag-
nosed by PET-CT at 16 weeks of age and confirmed at autopsy
(Fig. 2A; Supplementary Fig. 1C; Supplementary Table 1). Localized
HO lesions were observed in 95% (19/20) Tie2CRE/+;Bmp2tg/tg
animals by nano PET-CT (Supplementary Table 1, Supplementary
Videos 1–5). Only one of 20 mice remained HO-free (Supplemen-
tary Table 1). HO was manifested as fused cervical spine and
scapula extensions (47.2%) resulting in severe scoliosis (Fig. 2A;
Supplementary Videos 1,2), and as bony plaques adjacent to the
chest wall (55%; Supplementary Videos 3). Several animals (65%)
displayed bone outgrowths in hindlimbs (Supplementary Table 1;
Supplementary Movies 4,5). At 16 weeks, 70% of animals
presented HO in multiple areas, while by 20 weeks, 100%
presented severe HO lesions extending to most of the areas
described (Supplementary Fig. 1C, Supplementary Table 1 and
Supplementary Video 6). Of 7 heterozygous Tie2CRE/+;Bmp2tg/+
animals analyzed by nano PET-CT at 16 and 32 weeks, only 2
developed mild lesions by 32 weeks (Supplementary Table 1 and
Supplementary Fig. 1D). Circulating Bmp2 levels for heterozygous
transgenic mice at 24 weeks was 1.5-fold compared with WT
(Supplementary Fig. 1E), while Bmp2 levels of homozygous
transgenic Tie2CRE/+;Bmp2tg/tg animals were 5–6 fold, suggesting
that HO is highly sensitive to Bmp2 levels.
HO was associated with typical histopathological changes,
including mononuclear cell infiltration (Fig. 2B, a and a’),
fibroblast accumulation (Fig. 2B, b and b’), and chondro-
osteogenic overgrowths (Fig. 2B, c, c’, d and d’) and development
of a BM-like stroma (Fig. 2B, d and d’). Chondrogenic tissue
organization in the epiphysis and head of the femur and tibia
was similar in Tie2CRE/+;Bmp2tg/tg and WT animals (Fig. 2C, a, a’, b).
However, additional cartilage was present in joints of Tie2CRE/+;
Bmp2tg/tg animals, including osteochondral patches surrounding
the tibial head and neck (Fig. 2C, b and b’). Ectopic bone was
present adjacent to the normal bone in transgenic animals
(Fig. 2C), and bone mass was increased in Tie2CRE/+;Bmp2tg/tg
compared to WT animals (Fig. 2C, c, c’, d and d’). We measured
bone mass density (BMD) in tibia and femur bones in WT and
Tie2CRE/+;Bmp2tg/tg animals [39]. BMD was increased about 20% in
Tie2CRE/+;Bmp2tg/tg mice compared to WT (9226 vs. 7720
Hounsfield Units; Supplementary Fig. 2A, B). Ossification of the
meniscus (Fig. 2C, d and d’) would likely result in limb
immobilization in transgenic animals. Thus, Tie2CRE/+;Bmp2tg/tg
mice show similar histopathological lesions found in human HO.
Hematopoietic progenitors contribution to HO in Tie2CRE/+;
Bmp2tg/tg mice
Tie2+ cells are potential osteogenic progenitors in HO [21, 30, 31]. To
characterize the hematopoietic contribution to HO in Tie2CRE/+;
Bmp2tg/tg mice, bone marrow (BM) was isolated from normal, and
ectopic bone of fore- and hindlimbs, scapulae, hips, and sternum of
Tie2CRE/+;Bmp2tg/tg mice, and processed separately. The combined
total BM (normal and ectopic bone) cell number was increased in
Tie2CRE/+;Bmp2tg/tg mice (Fig. 3A, left panel), although there were
important variations in the total hematopoietic cell number in ectopic
bone (Fig. 3A, right panel) due to uneven HO in individual animals.
Granulocyte-monocyte (GM) precursors colony forming-units
(CFU) were increased in Tie2CRE/+;Bmp2tg/tg mice (Fig. 3B), suggest-
ing that enforced Bmp2 expression in Tie2+ cells drives hemato-
poietic progenitor expansion. Interestingly, ectopic bone marrow
formed CFU-GM, to a lesser extent than normal WT or tg BM
(Fig. 3B, right panel). CFU-GM isolated from transgenic spleen and
peripheral blood (PB) were unchanged (Supplementary Fig. 1D).
To support the evidence of increased hematopoietic progenitors
in Tie2CRE/+;Bmp2tg/tg BM, we analyzed Lin-Sca1+c-Kit+ (LSK) cells.
This population was increased in total BM (normal and ectopic
bones) of Tie2CRE/+;Bmp2tg/tg mice (Fig. 3C, left panel), and present in
ectopic BM (Fig. 3C, middle panel). Consistent with widespread Tie2
expression in hematopoietic progenitors [37], more than 93% of the
LSK population in tg normal and ectopic BM was GFP+ (Fig. 3C, right
panel), reflecting an important contribution of hematopoietic cells to
ectopic Bmp2 production and BM formation.
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Fig. 1 Constitutive endothelial Bmp2 overexpression results in aortic valve dysfunction and pre-calcification. A Circulating Bmp2 levels
detected by ELISA in WT and Tie2 CRE/+;Bmp2 tg/tg adult mice serum. B Quantification of pulmonary acceleration time (PAT, left panel), and PAT-
ejection time ratio (PAT/PET, right panel) measured by ultrasound on 16-week-old WT and Tie2 CRE/+;Bmp2 tg/tg mice. C Quantification of the
aortic valve velocity (AoV Mean and Peak Vel), and pressure gradient (AoV Mean and Peak Grad) measured by ultrasound. D Representative
images of acquired data of the aortic velocity peaks detected by ultrasound in WT (≈1000mm/s) and tg animals (≈1200mm/s). E Top panels:
Masson trichromic staining on consecutive sections of aortic valve from 18-week-old WT and Tie2 CRE/+;Bmp2 tg/tg mice. Chondrocyte island
(arrow) in aortic annulus at the base of the leaflet. Bottom panels: Localization of lipid droplets (arrowheads) identified by Oil Red O staining.
Unpaired t test, two tails, mean ± SD *P < 0.05; ***P < 0.001; ****P < 0.0001; ns, non-significant. Scale bar 200 µm.
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We queried whether inflammation was required for HO in
Tie2CRE/+;Bmp2tg/tg mice. FACS analysis revealed that the pro-
inflammatory CD11b+Gr1+ cell population was increased in
combined (normal and ectopic) Tie2CRE/+;Bmp2tg/tg BM (Fig. 3D,
left panel), whereas there was no difference in tg or WT BM
(Fig. 3D, right panel). Circulating CD11b+Gr1+ cells were margin-
ally increased (p= 0.06; Fig. 3E, left panel), although their numbers
increased in PB (Supplementary Fig. 1E, left panel), indicating that
a greater proportion of inflammatory cells are mobilized from
Tie2CRE/+;Bmp2tg/tg BM. We monitored inflammation onset in 4 WT
and 4 Tie2CRE/+;Bmp2tg/tg mice for 7 weeks (at 13, 19, and 21 weeks;
Fig. 3E, right panel), and by the time all the Tie2CRE/+;Bmp2tg/tg mice
had developed HO, their inflammatory cell numbers had increased
in PB (Supplementary Fig. 3E, right panel).
We tested fibroblast (Fb) and osteoblast (Ob) colony–forming
potential in Tie2CRE/+;Bmp2tg/tg normal and ectopic BM. Fb (Fig. 3F)
and Ob (Fig. 3G) CFUs readily formed from WT and transgenic
mice BM, from ectopic BM of transgenic animals (Supplementary
B. Prados et al.
4
Cell Death and Disease          (2021) 12:729 
Fig. 1F). Both CFU-Fbs and CFU-Obs were increased in combined
tg BM (normal and ectopic) and tg BM (Fig. 3F, G), suggesting that
forced Bmp2 expression in Tie2+ cells expands the fibro-
osteoblastic BM progenitor population.
BMP2 is known to promote erythropoiesis [40]. By FACS
analysis, ProE, EryA, EryC, and erythrocytes (high-Ter119+) were
all significantly increased in tg mice BM (Supplementary Fig. 1E),
suggesting that forced BMP2 expression in Tie2+ cells promotes
erythropoiesis in vivo.
Hematopoietic cells overexpressing BMP2 do not trigger HO
in wild-type mice
We queried if Tie2+ Bmp2-expressing BM hematopoietic cells can
give rise to HO in wild-type (WT) mice. Eight-week-old lethally
irradiated C57/BL6 WT mice were transplanted with BM hemato-
poietic stem cells (HSCs) from either WT (Bmp2tg/+) or Tie2CRE/+;
Bmp2tg/+ mice (Supplementary Fig. 3A). Hematopoietic cell
(CD45+) engraftment, was examined by FACS five months after
BM transplantation and thereafter bimonthly for over a year. WT
mice transplanted with WT HSCs engrafted between 95-100 % of
CD45+ cells. WT mice transplanted with Tie2CRE/+;Bmp2tg/+ HSC
engrafted 80-90 % of CD45+ cells (Supplementary Fig. 3B). Bmp2
increased almost four-fold after 10 months in WT animals
transplanted with Bmp2-overexpressing hematopoietic cells
(Supplementary Fig. 3C). Hematopoietic-derived Bmp2 accounted
for ~50% Bmp2 levels found in Tie2CRE/+;Bmp2tg/tg mice (compare
Fig. 1A and Supplementary Fig. 3B).
We analyzed multi-lineage reconstitution in PB (CD11b+, B220+
and CD3+) by FACS every month for 12 months. Whilst myeloid
reconstitution was unaffected, B and T lymphoid cells were
decreased at all time points (Supplementary Fig. 3D). BMP2/4 has
been shown to antagonize T-cell lineage differentiation [41, 42].
None of the transplanted animals developed HO by Nano-PET-CT
(data not shown), even 12 months after the BM transplant assay.
Thus, Bmp2 secreted by hematopoietic Tie2CRE/+;Bmp2tg/+ cells in
WT mice is not sufficient to drive HO. Alternatively, local
expression of other Tie2-Cre-targeted cells is crucial to initiate
flare-ups and HO.
Transplanting WT BM into Tie2CRE/+;Bmp2tg/tg mice delays HO
onset
We asked whether Bmp2 dosage affected HO formation in Tie2CRE/+;
Bmp2tg/tg mice. Eight weeks-old lethally irradiated CD1 mice were
used for transplant assays, because Tie2CRE/+;Bmp2tg/tg mice were in
a CD1-enriched mixed background. WT mice were transplanted with
5 million BM nucleated cells from WT (Bmp2tg/tg; n= 10) or Tie2CRE/+;
Bmp2tg/tg (n= 10) mice (Fig. 4A and Supplementary Fig. 4A). A
second group of 8-week-old lethally irradiated Tie2CRE/+;Bmp2tg/tg
mice (n= 7) was transplanted with WT (Bmp2tg/tg) HSCs in CD1-
enriched mixed background (Fig. 4A). Three transplanted WT mice
died after 19 days, and could not be analyzed further. In four, GFP
was either not expressed or expressed in 15–20% of total HSCs
(Supplementary Fig. 4C, left panel) and excluded. Three surviving
mice expressed GFP (Supplementary Fig. 3C, right panel). Circulating
Bmp2 levels in two of these mice were comparable to those found
in Tie2CRE/+;Bmp2tg/tg mice (5.9-fold increased) (Supplementary Fig.
4B). Transgenic mice transplanted with WT HSCs had comparable
Bmp2 levels to controls (Fig. 4B), confirming the hematopoietic
origin of circulating Bmp2.
To determine lineage contributions to BM reconstitution, blood
samples were analyzed by FACS monthly over five months
following transplantation. CD45+ cell engraftment in control and
WT groups transplanted with Tie2CRE/+;Bmp2tg/tg HSCs (n= 3) was
comparable, reaching 90-98% (Supplementary Fig. 4C). Tie2CRE/+;
Bmp2tg/tg animals transplanted with WT HSCs reached 80–95%
engraftment (Fig. 4C). Myeloid CD11b+ cell engraftment was
similar between groups (Supplementary Fig. 4D and Fig. 4D, left
panel). Lymphoid B220+ cells increased during the first month
compared to controls (Supplementary Fig. 4D, and Fig. 4D, middle
panel). In contrast, CD3+ T lymphoid cells were not reconstituted
to WT levels when transplanted with Tie2CRE/+;Bmp2tg/tg HSCs
(Supplementary Fig. 4D, right panel), as observed previously
(Supplementary Fig. 3B). Tie2CRE/+;Bmp2tg/tg animals transplanted
with WT HSCs did not recover normal CD3+ levels compared to
controls (Fig. 4D, right panel). Thus, B Lymphoid cells were initially
depleted in Tie2 CRE/+;Bmp2 tg/tg mice transplanted with WT HSC
but recovered, while T cells remained depleted for the entire
duration of the experiment.
Tie2CRE/+;Bmp2tg/tg mice transplanted with WT hematopoietic
cells eventually develop HO, likely because HO was already taking
place at the time of transplantation (8 weeks). Five animals
presented typical HO with variable severity, including complete
hindlimb immobilization by 16 weeks (n= 1), dorsal vertebrae at
20 weeks (n= 1), and hindlimb and dorsal vertebrae at 22 weeks
(n= 2) (Fig. 4E). One mouse presented a fat cyst dorsally but no
HO, and another developed HO in dorsal vertebrae at 26 weeks
(not shown). One mouse remained asymptomatic 37 weeks after
transplant. Thus, 5 out of 7 Tie2CRE/+;Bmp2tg/tg mice reconstituted
with WT hematopoietic cells developed HO, with delayed onset
compared to non-transplanted animals. Disease onset in Tie2CRE/+;
Bmp2tg/tg mice occurred at 16–28 weeks in transplanted mice,
versus 8–18 weeks in non-transplanted ones (Fig. 4F, left panel).
Tie2CRE/+;Bmp2tg/tg mice transplanted with WT HSCs survive
10 weeks longer than non-transplanted transgenics (Fig. 4F, right
panel). Therefore, Bmp2 expression in non-hematopoietic cells is
essential for HO development, and concomitant Bmp2 expression
by hematopoietic cells accelerates this process.
Chondro-osteogenic differentiation is associated with BMP
signaling activation in FAP cells
Tie2 marks a subset of resident skeletal muscle cells [31], which
potentially contribute to HO. Tie2CRE/+;Bmp2tg/tg cartilage and
bone lesions showed GFP+ co-staining with IB4+ (Fig. 5A), co-
localizing with Tie2+ fibroblastic/adipocytic skeletal-muscle cells
Fig. 2 Constitutive Tie2-driven Bmp2 expression causes HO lesions in mice. A Nano PET-computed tomography (CT) images of 16-week-old
WT and Tie2 CRE/+;Bmp2 tg/tg mice showing ectopic bone lesions close to ribs, scapulae, and neck (red arrows, ribs, rb; nk, neck; dorsal vertebrae,
dv). B H&E staining on sections of skeletal muscle of the hindlimbs of Tie2 CRE/+;Bmp2 tg/tg mice showing histological features typical of HO
lesions. a. Evidence of inflammation in HO lesion. a’ Damaged skeletal muscle fibers with central nuclei (arrows), mononuclear infiltration
(black arrowheads), and fat cells (white arrowheads). b, b’ Area of massive fibroblast accumulation. c Ectopic bone in skeletal muscle (arrows)
next to tibia. c’ Chondro-osteogenic areas with chondrocytes (white arrowhead), and osteoblasts (black arrowheads). d, d’ Mature ectopic
bone with colonizing bone marrow cells (arrows), chondrocytes (white arrowhead), and osteoblasts (black arrowhead). C Top panels: Alcian
blue staining of sections of WT and Tie2 CRE/+;Bmp2 tg/tg knee joint. a, a’ In WT, chondrocyte tissue (in blue) is located in the epiphysis region,
tip of the bone (black arrowheads), and head of the fibula (arrow). b, b’ In Tie2 CRE/+;Bmp2 tg/tg, chondrocyte tissue is located in the epiphysis
region at the tip of the bone (black arrowheads), accumulated in connective tissue (arrow) of the meniscus and head of the fibula
(white arrow) and chondrogenic areas (white arrowhead) inside the skeletal muscle. Bottom panels: Alizarin red staining of WT and Tie2 CRE/+;
Bmp2 tg/tg knee joint. c, c’ In WT, osteogenic tissue (in red) is located in the epiphysis region and tip of the bone complementary to
chondrogenic areas (white arrowheads). d, d’ Intense staining in the head of Tie2 CRE/+;Bmp2 tg/tg joints (white arrowheads in (d’)). Extra
ossification inside the skeletal muscle and head of the fibula (arrows in (d)), and the meniscus (black arrowhead). Scale bar 200 µm.
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(Supplementary Fig. 5A, white arrowheads). GFP+ infiltrating
inflammatory cells expressing IB4 were detected in fibroprolifera-
tive areas (Supplementary Fig. 5A), and have been previously
described [43]. GFP-expressing fat cells were identified based on
their peripheral nuclei (Supplementary Fig. 5B, b’). Phospho-
Smad1/5-stained nuclei were detected in scattered cells in
fibroproliferative areas (Fig. 5A, a’ and b’ and Supplementary
Fig. 5B, a’), as well as among fat cells (Supplementary Fig. 5B, b’).
Bmp2 activation may be non-cell autonomous because p-Smad-
positive cells did not express GFP (Fig. 5A, a’ and b’ and
Supplementary Fig. 5B, a’).
The chondrogenic marker Sox9 was expressed in ectopic bone
chondrocyte nuclei (Supplementary Fig. 5C, left panel). Scattered
Sox9+ nuclei were also found in GFP-expressing fibroblasts
(Supplementary Fig. 5C, d’) and damaged skeletal muscle fiber
cytoplasm identified by central nuclei (Fig. 5B, c’ and d’, and
Supplementary Fig. 5C, c’). This expression pattern was also
observed in areas next to HO, although involving very few
nuclei (Supplementary Fig. 5C, c’, open arrowheads). The
osteogenic marker Osterix, was also detected amongst Sox9-
expressing cells in consecutive sections (Fig. 5C, e’, and f’) and in
ectopic bone osteoblasts (Supplementary Fig. 5D, arrowheads).
B. Prados et al.
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Fig. 3 Hematopoietic stem cells contribute to HO in Tie2 CRE/+;Bmp2 tg/tg mice. A Quantification of bone marrow (BM) cellularity. Left, total
BM (combined BM of transgenic (tg) and ectopic bone (EB)) cellularity is increased in Tie2 CRE/+;Bmp2 tg/tg mice. Right, cellularity of WT BM, tg
BM, and ectopic BM. Ectopic BM cellularity is highly variable. B Quantification of granulocyte, monocyte colony forming units (CFU_GM). Left,
total BM (tg+ EB) CFU-GM was increased in Tie2 CRE/+;Bmp2 tg/tg mice. Right, ectopic BM can give rise to CFU-GMs. C Quantification of the
FACS-isolated Lin-Sca1+cKit+ (LSK) population. Left, the LSK population is increased in Tie2 CRE/+;Bmp2 tg/tg BM. Middle, LSK progenitors in
ectopic BM are detectable and below normal. Right, the bulk (93.6% in tg and 93.2% in ectopic BM) of the LSK population in Tie2Cre/+;Bmp2tg/tg
BM is GFP+. D Quantification of the FACS-isolated pro-inflammatory Cd11b+Gr1+ cells from BM. Left, the Cd11b+Gr1+ population is increased
in total Tie2 CRE/+;Bmp2 tg/tg BM (tg+ EB). Right, varying presence of Cd11b+Gr1+ cells in ectopic BM. E. FACS-isolated pro-inflammatory
Cd11b+Gr1+ cells from PB. Left, Cd11b+Gr1+ cells are marginally increased in Tie2 CRE/+;Bmp2 tg/tg PB with HO. Right, Cd11b+Gr1+ population
at different time points, 13, 19, and 21 weeks. At 21 weeks, when mice present HO, pro-inflammatory cells increase in Tie2 CRE/+;Bmp2 tg/tg.
F Representative eosin staining of CFU-fibroblast (Fb). G Representative alkaline phosphatase staining of CFU-osteoblast (Ob). H Quantification
showing increased CFU-Fb and CFU-Ob in Tie2 CRE/+;Bmp2 tg/tg BM. A, B, C, D, H, for WT and Tie2 CRE/+;Bmp2 tg/tg tg or tg+ EB BM groups,
unpaired t test, two tails, mean ± SD *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, ns non-significant. E Right panel, two-way ANOVA and
Sidak’s correction.
Fig. 4 Transplanting WT BM into transgenic Tie2Cre/+;Bmp2tg/tg mice delays HO onset. A Schematic representation of transplant assays. WT
(CD1) and Tie2Cre/+;Bmp2tg/tg mice were transplanted with WT BM cells. B Circulating Bmp2 levels are maintained in each group 3 months after
transplant. C Hematopoietic cell engraftment. FACS-quantification of CD45+ cells from PB. Tie2CRE/+;Bmp2tg/tg and WT mice show similar HSC
engraftment. D FACS-quantification of myeloid (CD11b+), B Lymphoid (B220+) and T Lymphoid (CD3+) cells in the two groups of transplanted
animals. E Nano-PET-CT imaging of transgenic Tie2CRE/+;Bmp2 tg/tg mice transplanted with WT HSC. These animals develop HO (red arrows) in
ribs, hind limbs, and dorsal vertebrae (ribs, rb; hind limbs, hl; and dorsal vertebrae, dv) at 8, 12, and 14 weeks after transplant, suggesting that
ectopic bones formation started before transplant. F Representation of the variability of HO onset in non transplanted Tie2CRE/+;Bmp2tg/tg mice
and Tie2CRE/+;Bmp2tg/tg transplanted with WT HSCs showing significant delay in the onset of HO (8–18 weeks versus 16-28w). Kaplan-Meier
curve showing that Tie2CRE/+;Bmp2tg/tg mice transplanted with WT HSCs survive 10 weeks longer on average non-transplanted transgenic mice.
C, D Two-way ANOVA and Sidak’s correction **P < 0.01; F unpaired t test, two tails, mean ± SD. t test ****P < 0.0001. E Survival curve and
survival curve analysis, **P < 0.01.
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Fig. 5 Tie2Cre/+;Bmp2tg/tg resident skeletal muscle cells are characterized by pSmad1/5 and chondro-osteogenic marker expression, and
increased fibro-adipogenic progenitors. Immunodetection of indicated osteo-chondrogenic marker proteins (red), with GFP (green), IB4
(white) and DAPI (blue), on consecutive WT or Tie2 CRE/+;Bmp2 tg/tg hindlimb skeletal muscle sections, A Nuclear immunostaining of GFP+
pSmad 1/5 (arrows) interspersed in muscle interstitium (a’ and b’). White arrowheads indicate GFP+ adipocytes. B Cytoplasmic Sox9
immunostaining in cells (arrows in c’ and d’) surrounded by damaged skeletal muscle fibers identified as central nuclei (open arrowheads in
c’). C. Nuclear immunostaining of Osterix (Osx) in cells surrounded by fibers (arrows in e’ and f’). Arrowheads indicate strong Osx
immunostaining in ectopic bone emerging areas. Arrowheads in f’ indicate GFP+ adipocytes. D Top, FACS quantification of the
CD45-PDGFRα+Sca1+ fibro-adipogenic (FAP) population in Tie2 CRE/+;Bmp2 tg/tg skeletal muscle. Bottom, FACS quantification showing that 84%
of the CD45-GFP+ cells are PDGFRα+Sca1+ cells. E Immunostainings of pSmad1/5/8 and PDGFRα (red), GFP (green), and DAPI (blue), on
consecutive Tie2 CRE/+;Bmp2 tg/tg hindlimb skeletal muscle sections showing expression in connective tissue surrounding muscle fibers. Bottom
panels are magnifications of areas indicated in top panels. Arrows indicate co-localization of pSmad1/5 and PDGFRα cells. Arrowheads
indicate co-localization of PDGFRα and GFP+ cells. Cells expressing the three markers are indicated by arrows and arrowheads (middle bottom
panel). Scale bars 200 µm. Unpaired t test, two tails, mean ± SD *P < 0.05; ****P < 0.0001.
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Moreover, Osterix staining was observed in larger central nuclei
of damaged fibers next to ectopic bone (Supplementary Fig. 5D,
e’, and f’).
The expression of chondro-osteogenic markers in damaged
skeletal muscle fibers adjacent to ectopic bone, suggests an active
repair process. The number of satellite cells labeled by
CD45+Sca1-CD34+α7int+ was not significantly different between
Tie2CRE/+;Bmp2tg/tg and WT hindlimb skeletal muscle (Fig. 5D, left
panel). There were no GFP+ satellite cells among Tie2CRE/+;Bmp2tg/tg
skeletal muscle cells (Fig. 5D, right panel), suggesting that satellite
cells are not overexpressing Bmp2 and probably not directly
implicated in HO in Tie2CRE/+;Bmp2tg/tg mice.
Resident FAPs are CD45-Tie2+PDGFRα+Sca1+ have been
proposed as HO cells-of-origin [26]. FAPs were readily increased
in Tie2CRE/+;Bmp2tg/tg skeletal muscle (Fig. 5D, top panel),
accounting for 84% of the resident Tie2+ cells (Fig. 5D, bottom
panel). In fact, among fibroproliferative areas, the majority of
pSmad1/5-, PDGFRα- (Fig. 5A, a’, b’; 5E, left panels; Supplementary
Fig. 5B, a’, b’ and 5E, middle panels), and Sox9-expressing cells
were GFP+ (Supplementary Fig. 5C, c’, d’ and 5E right panels). In
contrast, Sox9-or Ostx- expressing damaged fibers did not express
GFP (Fig. 5B c’, d’; 5C e’, f’ and Supplementary Fig. 5C c’; 5D, e’, f’),
suggesting that most FAPs are Tie2+ cells, and/or that Tie2
expression is silenced during FAP differentiation.
DISCUSSION
Tie2CRE/+;Bmp2tg/tg mice develop HO, apparently spontaneously
within 4 months. Normal skeletogenesis is not perturbed, with no
obvious HO in juvenile mice, while adult mice present a variety of
skeletal deformities including scoliosis, and spinal defects
resembling lesions found in HO patients. Tie2CRE/+;Bmp2tg/tg mice
may allow for further studies of therapies designed to mitigate the
effects of HO.
Bmp2 is a key pathway activated and causally linked to calcific
aortic valve disease in animal models [38, 44–46]. Tie2CRE/+;Bmp2tg/tg
mice present pulmonary valve hypertension and pre-calcific aortic
valve dysfunction by 16–18 weeks, characterized by fibrosis, lipid
deposition and chondrogenesis. Bmp2 overexpression promotes
ectopic EMT in developing Nkx2.5CRE/+;Bmp2tg/+ embryos [35],
suggesting that EMT might contribute to pro-calcific disease in
adults. However, there is lack of evidence for EMT contributing to
adult valve disease pathology [47], and further studies are
required. Tie2CRE/+;Bmp2tg/tg mice develop systemic HO between
8–18 weeks precluding a meaningful study of valve changes,
but the effect of ageing over a longer-period might be assessed in
Tie2CRE/+;Bmp2tg/+ heterozygotes, which are healthy up to
32 weeks.
Our transplant studies indicate that while Bmp2 transgenic
progenitors contribute BM stem cell components, the HO
chondro-osteogenic stem/progenitor cell is not BM-derived,
consistent with previous studies [28, 29]. Otherwise, hematopoie-
tic/endothelial Bmp2 overexpression profoundly affects hemato-
poiesis. LSK stem cells, myeloid CFU-GM and Cd11b/Gr11 cells,
and fibroblast and osteoblast progenitors are all expanded in
transgenic mice. Tie2CRE/+;Bmp2tg/tg mice display increased Cd11b/
Gr11 cells in BM and PB, and increased erythroid lineage
differentiation, consistent with in vitro findings [40]. Overall
increased BM cellularity is consistent with HSC niche enlargement,
enhancement of HSC self-renewal and pool size. Within the BM
niche, non-canonical BMP signaling regulates intrinsic HSC
maintenance in vivo [48–50], and is implicated in determining
the HSC fate, by promoting a pro-lymphoid transcriptional
program and sustaining lymphoid-biased HSC commitment
[48, 49].
The CD45-PDGFRα+Sca1+ population expansion in skeletal
muscle identifies FAPs as potential cells of origin in Tie2CRE/+;
Bmp2tg/tg mice. Evidence for a soft tissue chondro-osteoprogenitor
“niche” in damaged skeletal muscle of Tie2CRE/+;Bmp2tg/tg mice is
suggested by the presence of central nuclei, co-immunostaining
of isolectin B4 (also a leukocyte marker), pSmad1/5, Sox9, and
osterix, in chondro-osteogenic areas of differentiation. Tie2+ FAP
osteoprogenitors are identifiable by PDGFRα and Sca1 cell surface
expression [32], bipotent fibro/adipogenic potential [26, 27], and
contribution to ectopic cartilage and bone [31, 32]. HO lesions in
Tie2CRE/+;Bmp2tg/tg mice might be attributed to local Bmp2 release
through autocrine/paracrine mechanisms. Conversely, resident
skeletal muscle satellite cells (CD45−CD34+α7int+) that give rise to
differentiated myocytes [51] were unchanged, suggesting that
muscle regenerative potential is not altered. Further studies are
required to characterize other progenitor populations residing in
skeletal muscle, ligaments and tendons [31, 52] in the context of
Bmp2-driven HO.
Previous BMP overexpression studies using a variety of
promoters failed to cause HO (reviewed in [53]), because the
relevant progenitor cell type had not been targeted. One
exception is the transgenic mouse overexpressing BMP4 under
control of neuron-specific enolase (Nse) promoter [53, 54]. Our
Tie2CRE/+;Bmp2tg/tg mice resembles this model, matching a
stereotyped spreading pattern of HO formation. Neither the
NSE-BMP4 model, nor our Tie2CRE/+;Bmp2tg/tg model recapitulate
any of the congenital phenotypes associated with FOP. Moreover,
direct versus indirect Bmp effects on target stem/progenitor cell
populations cannot be assessed using these models. Nevertheless,
Tie2CRE/+;Bmp2tg/+ mice are viable, and develop HO within weeks.
This HO model does not require surgical procedures involving the
implantation of a BMP-loaded matrix and Bmp2 dosage can be
modulated via copy number gene expression. Tie2CRE/+;Bmp2tg/tg
mice are maintained on a heterozygote background, so that a
single cross allows for the generation of experimental animals.
MATERIALS AND METHODS
Mouse strains and genotyping
The following mouse strains were used: male and female mixed
background C56BL/6-CD1 R26CAGBmp2tg [35] and Tie2CRE [37]. For
simplicity, R26CAGBmp2tg/+ and R26CAGBmp2tg/tg are abbreviated in the
text and figures as Bmp2tg/+ and Bmp2tg/tg, respectively. Details of
genotyping will be provided upon request. Recipient transplanted animals
were WT C56BL/6, CD1 or Tie2Cre/+;Bmp2tg/+ animals. Animal studies were
approved by the CNIC Animal Experimentation Ethics Committee and by
the Community of Madrid (Ref. PROEX 83.8/20). Animal procedures
conformed to EU Directive 2010/63EU and Recommendation 2007/526/
EC regarding the protection of animals used for experimental and scientific
purposes, enforced in Spanish law under Real Decreto 53/2013.
ELISA
Blood samples were taken by submandibular vein puncture from different
groups: control WT and Tie2Cre/+;Bmp2tg/tg mice at 16 weeks of age (n= 10/
each group); control WT and heterozygous Tie2Cre/+;Bmp2tg/+ at 24 weeks
of age (n= 6/each group). 1 year after transplant, WT animals transplanted
with WT BMCs, n= 6, and WT animals transplanted with Tie2Cre/+;Bmp2tg/+
BMCs, n= 8; 3 months after transplant WT animals transplanted with WT
BMCs (n= 7) and Tie2Cre/+;Bmp2tg/+ animals transplanted with WT BMCs
(n= 4) were analyzed. Serum was obtained by centrifugation at 4000 rpms
for 10min at RT. Circulating Bmp2 was measured by using the human
BMP2 ELISA construction kit (Antigenix America Inc. RHF913CKC) under the
manufacturer´s instructions.
Ultrasound
Mice were anaesthetized by inhalation of isoflurane and oxygen (1.25%
and 98.75% respectively) and examined by a 30 MHz transthoracic
echocardiography probe. Images were obtained with VEVO 2100
(VisualSonics, Toronto, Canada) from Tie2Cre/+;Bmp2tg/tg (n= 10) and WT
(n= 9) littermates. Short axis and long axis, B Mode, and 2D M-Mode views
were obtained from the M mode by an expert in ultrasound in a blind
fashion as described previously [55]. From these images, left ventricle (LV)
function was estimated by fractional shortening (FS) and ejection fraction
(EF). For FS measurements a long or short-axis view of the heart was
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selected to obtain an M mode registration in a line perpendicular to the LV
septum and posterior wall at the level of the mitral chordae tendinea.
Pulmonary acceleration time (PAT) and ejection time (PET) were measured
in the parasternal short-axis view by pulsed-wave Doppler of pulmonary
artery flow [56]. B-mode and color-Doppler guided pulsed-wave Doppler
was used to record the maximal transvalvular jet velocity. Specifically, to
avoid Doppler misalignment, coaxial interrogation of the aortic flow was
ensured by the operator, and all the measurements were obtained using
an angle of interrogation <30°. To correct for flow dependence, we
computed an EF velocity ratio (EFVR= EF (%)/maximal aortic velocity [m/s])
as an additional indicator of disease severity [57].
Positron emission tomography-computed tomography (PET/
CT) imaging
In vivo CT imaging was performed on a nanoPET/CT small animal system
(Mediso, Hungary) equipped with a micro-focus X-ray source and a high-
resolution radiation-imaging device featuring a 1024 × 3596 pixel photo-
diode array. 16-week-old Tie2Cre/+;Bmp2tg/tg (n= 12) and WT (n= 10), or 20
week-old Tie2Cre/+;Bmp2tg/tg (n= 5); 16 and 32-week-old Tie2Cre/+;Bmp2tg/+
(n= 7) and WT (n= 6) or Tie2Cre/+;Bmp2tg/tg transplanted with WT BMCs (16
(n= 1), 20 (n= 1), 22 (n= 2) and 26 (n= 1) weeks were analyzed. The mice
were anesthetized using isoflurane 2% and 1.8 L/min oxygen flow, and
positioned in a thermo regulated (38.7 °C) mouse bed with an ophthalmic
gel in their eyes to prevent retinal drying. The scan parameters used for the
CT measurements were an X-ray beam current of 145 µA and a tube
voltage of 55 kVp. Acquisitions and reconstruction were performed by an
expert in PET/CT in a blind fashion using proprietary Nucline software
(Mediso, Hungary) and analyzed by a whole-body bone 3D volume
rendering using OsiriX software (Pixmeo, Switzerland).
Bone mass spectrometry
Nano-PET-CT acquired and 3D-reconstructed images from 16-week-old WT
and Tie2Cre/+;Bmp2tg/tg animals (n= 3 of each group) were further analyzed
for bone mass densitometry. Hind limbs mean attenuation coefficient of
X rays expressed in Hounsfield Units was measured after segmenting
bones using the Multimodality Workstation MMWKS [39].
Histology
Skeletal muscles and bone tissue (and ectopic bone in transgenic animals)
were fixed in 4% PFA for 24 h at 4 °C, and after decalcification with
ImmunoCal (StatLab, Fisher scientific) embedded in paraffin or sucrose
treated to be cryopreserved in OCT. Hematoxylin/eosin (H&E), Masson´s
trichromic, Alizarin red, and Alcian blue stainings were performed
according to standard protocols on paraffin-embedded 7 μm sections.
Oil Red, staining was performed according to standard protocols on 5 μm
cryosections.
Immunohistochemistry
Paraffin-embedded 7 μm sections of hind limb tissues were citrate-
unmasked and stained with the following primary antibodies: polyclonal P-
Smad 1/5 (1:100; (41D10) 9516, Cell Signaling Technology), polyclonal Sox9
(1:100, Santa Cruz Biotechnology, sc-20095), polyclonal Sp7/Osterix (1:100,
Abcam ab22552), monoclonal GFP living Colors (1:100 Clontech 632381) or
polyclonal GFP (1:200; Origene/Acris lab R1091P) and monoclonal CD140a
(PDGFRα) (1:100 (APA5) ThermoFisher 17-1401-81). Secondary antibodies
were as follows: goat-anti-rabbit HRP (P0448, DakoCytomation; 1:100),
goat-anti-mouse HRP (P0447, DakoCytomation; 1:100) goat-anti-rat (Ther-
moFisher, 31470 1:100) HRP-coupled secondary antibodies and donkey-
anti-goat-HRP (ThermoFisher, PA128664). The signal was tyramide signal
amplified (TSA) with coupling to Cy3 (NEL744, Perkin Elmer; 1:100) or
fluorescein ((NEL744 or NEL741 Perkin Elmer; 1:100)
Confocal imaging
Confocal images of tissue sections were acquired with a Nikon A1R laser
scanning confocal microscope and NIS-Element SD Image Software.
Images of stained explants were collected as z-stacks. Z-projections and
lateral sections were assembled using ImageJ. Images were processed in
Adobe Photoshop Creative Suite 5.1.
CFU assays
16–20-week-old WT (n= 16) and Tie2Cre/+;Bmp2tg/tg animals (n= 20) were
sacrificed and blood samples were obtained by cardiac puncture. Spleen
and bones were dissected from posterior and anterior limbs, hips, and
sternum. Extra bone formations from transgenic animals were dissected
and processed separately. BM cells were obtained by crushing bones with
a mortar in PBS. The solution containing BM cells was separated, and the
remaining bone was treated with Collagenase I for 45min at 37 °C in a
shaking bath to obtain stromal cells. All samples were 70 μm–filtered. Red
blood cells were removed from BM and spleen samples using lysis buffer
(0.15 M NH4Cl for 10min at 4 °C) and cell number was determined.
Peripheral blood mononuclear cells were isolated from diluted-blood
(300 μl of PB mixed with 1.5 ml phenol-red-free RPMI). These samples were
added carefully over 2 ml of Lympholite-M (Cedarlane) and were carefully
layered on top and centrifuged without brake for 25min at RT. The halo
phase with mononuclear cells was centrifuged at 1500 rpms for 10min.
Cells were resuspended in 200 μl RPMI w/o phenol red. For CFU-GM, cells
were mixed with methyl-cellulose and seeded on low adherence p35mm
(BM 1 × 104 cells; Spleen 4 × 105 cells, PB 200 μl) by duplicate. The colonies
were scored after 7 days in culture. For CFU-Fb and CFU-Ob (WT, n= 13
and 14; Tg n= 19), cells were plated by triplicate in three wells of six-well
plates (1 × 106/well) in α-MEM+ 15% FBS. CFUs were stained and counted
after a week in culture.
BM transplantation assays
For BM transplantation assays we used 8-week-old male WT C57BL6 or
heterozygous Tie2Cre/+;Bmp2tg/+/− (mixed background) as donors, (n= 2
per transplantation assay) and two groups of male 8-week-old WT as
recipients (n= 7 and 8 per transplantation assay). Briefly, lethality
irradiated receptor mice (11 grays) were transplanted with 2 × 106 bone
marrow cells (BMCs) by tail vein injection. BMCs were obtained as
mentioned above in FACS analysis section. The homogenized samples
were filtered through a 40-μm mesh to obtain single-cell suspensions, and
depleted of red blood cells by lysis. For reciprocal transplantation assays
we used 8-week-old WT CD1 or Tie2Cre/+;Bmp2tg/tg as donors, (n= 2 per
transplantation assay) and two groups of 8-week-old WT CD1 (n= 10) or
Tie2Cre/+;Bmp2tg/tg (n= 7), as recipients without HO symptoms. In order to
check the engraftment of hematopoietic cells in each group of transplants,
we bled the animals every month after the transplant, until 4 (WT BMC into
Tie2Cre/+;Bmp2tg/tg) or 5 (Tie2Cre/+;Bmp2tg/tg BMC into WT) months post-
transplant.
Isolation of skeletal muscle cells
Skeletal muscle tissues (tibialis anterior, gastrocnemius, quadriceps)
were dissected and minced from hind limbs of wt and Tie2Cre/+;Bmp2tg/tg
9–11- week-old animals. The minced tissue was digested in Collagenase I
(0.25 %), and II (0.2 %) in DMEM/10% FBS for 1 hmin at 37 °C in a shaking
bath. Cells were washed with DMEM 2%FBS, 100- and 70-μm filtered,
washed with DMEM/2%FBS, and centrifuged. The pellet was resuspended
in PBS/2% FBS to determine cell number, centrifuged, and resuspend in
staining buffer (PBS/2%FBS).
FACS analysis
For BM FACS analysis, 16–20-week-old WT and Tie2Cre/+;Bmp2tg/tg animals
were sacrificed and bones were dissected as described in CFU assays
section. 1 × 106 cells were labeled with the following cocktail of antibodies:
LSKs (WT, n= 13; Tg, n= 17): biot-Lin (1:100, BD Biosciences 559971)/St-
APC/Cy7 (1:100, BD Biosciences 554063), C-Kit-PE-Cy7 (1:400, BD
Biosciences 558163), Sca1-PE (1:200, BD Biosciences cat no. 553336);
Erytrhoid lineages (WT, n= 4; Tg, n= 4) CD71-APC, BD Biosciences
567258); Ter-119-PE-Cy7 (1:100, BD Pharmigen 560509); Pro-inflammatory
cells (WT, n= 6; Tg, n= 7) CD11b-PE (1:200, BD Biosciences 553311); Gr1-
APC (1:100, BD Biosciences 553129) and DAPI for viability. The total
number of each BM lineage was calculated referred to the total number of
cells obtained from BM. Total number of spleen CFUs (WT, n= 5; Tg, n=
15) and PB-CFUs (WT, n= 11; Tg, n= 13), PB-pro-inflammatory cells
(16–20-week-old mice WT, n= 5; Tg, n= 4 or the group at 13, 19 or 21
week-old mice WT n= 3, tg n= 4) was calculated referred to the total
number of cells obtained from spleen or white blood cell number
determined by hematology. For transplants multi-lineage engraftment
FACS analysis peripheral blood cells were labeled with the following
cocktail of antibodies: hematopoietic cells CD45-APC (1:100, BD Bios-
ciences 559864), myeloid lineages CD11b-PE (1:200, BD Biosciences
553311), lymphocytes B biot-B220 (1:200, BD Biosciences 559864)/st-APC-
Cy7 (1:100), and lymphocytes T CD3-PERCP-Cy5 (1:200, BD Biosciences
560527). For muscle cells FACS analysis cells were labeled with the
following cocktail of antibodies: CD45-AV450 (1:200, BD Biosciences
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560501), Sca1-PE-Cy7 (1:200, BD Biosciences 558162), α7-Int-PE (1:100,
AbLab AB10STMW215), CD34-Alexa647 (1:40, BD Pharmigen 560230),
CD140a (PDGFRA) Monoclonal Antibody (APA5), Biotin (1ː200, Thermo-
Fisher 13-1401-82), streptavidin-APC-Cy7 (1:100, BD Biosciences 554063)
and 7AAD (1:100, BD Pharmigen 559925) for viability. Satellite cells were
identified as CD45+Sca1-CD34+α7int+ and fibro-adipogenic cells as
CD45-PDGFRα+Sca1+.
Statistics
Due to the high variability in HO onset and severity, the analysis was made
in groups n > 10 in some cases. Statistical assessment is indicated in the
figure legends. For each experiment comparing two groups, a mean ± SD is
represented and a two-tailed t test was performed. For experiments
comparing two groups at different time points, a mean ± SD is represented
at each timepoint and a two-way ANOVA followed by Sidak’s correction
was performed. *P < 0.05; **P < 0.01; ***P < 0.001; **** P < 0.0001.
DATA AVAILABILITY
Data sharing is not applicable to this article as no datasets were generated or
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